Next Article in Journal
Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo
Next Article in Special Issue
Antibacterial and Proliferative Effects of NaOH-Coated Titanium, Zirconia, and Ceramic-Reinforced PEEK Dental Composites on Bone Marrow Mesenchymal Stem Cells
Previous Article in Journal
Development of Gelatin-Coated Hydrogel Microspheres for Novel Bioink Design: A Crosslinker Study
Previous Article in Special Issue
Are Endodontic Solvents Cytotoxic? An In Vitro Study on Human Periodontal Ligament Stem Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 15
Issue 1
10.3390/pharmaceutics15010091
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Treated Dentin Matrix in Tissue Regeneration: Recent Advances

by
Fei Bi
1,2,
Zhijun Zhang
1,2 and
Weihua Guo
1,2,*
1
State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610017, China
2
Department of Pediatric Dentistry, West China School of Stomatology, Sichuan University, Chengdu 610017, China
*
Author to whom correspondence should be addressed.
Pharmaceutics 2023, 15(1), 91; https://doi.org/10.3390/pharmaceutics15010091
Submission received: 14 November 2022 / Revised: 20 December 2022 / Accepted: 22 December 2022 / Published: 27 December 2022
(This article belongs to the Special Issue Biomaterials and Agents: Pharmaceutical and Biomedical Applications in Dental Research)
Browse Figures
Versions Notes

Abstract

:
Tissue engineering is a new therapeutic strategy used to repair serious damage caused by trauma, a tumor or other major diseases, either for vital organs or tissues sited in the oral cavity. Scaffold materials are an indispensable part of this. As an extracellular-matrix-based bio-material, treated dentin matrixes have become promising tissue engineering scaffolds due to their unique natural structure, astonishing biological induction activity and benign bio-compatibility. Furthermore, it is important to note that besides its high bio-activity, a treated dentin matrix can also serve as a carrier and release controller for drug molecules and bio-active agents to contribute to tissue regeneration and immunomodulation processes. This paper describes the research advances of treated dentin matrixes in tissue regeneration from the aspects of its vital properties, biologically inductive abilities and application explorations. Furthermore, we present the concerning challenges of signaling mechanisms, source extension, individualized 3D printing and drug delivery system construction during our investigation into the treated dentin matrix. This paper is expected to provide a reference for further research on treated dentin matrixes in tissue regeneration and better promote the development of relevant disease treatment approaches.

Graphical Abstract

1. Introduction

Trauma [1], cancer [2], infection [3] and other major diseases [4] are causing serious damage to the human body and even costing human lives. Traditional treatment aimed at tissue damage or defects concentrates on the surgical removal of lesions [5,6,7] and conducting replacements with artificial products [8,9], other parts of the same body [10] or allo- [11]/xeno- [12] organ transplantation, which in some circumstances are considered to have limited effectiveness or present immunogenicity concerns. Fortunately, a new therapeutic strategy was found for this medical problem, that is, tissue engineering [13]. The basis of tissue engineering is to establish a three-dimensional complex of cells and bio-materials that mimic living tissue and can be used to reconstruct the morphology, structure and function of the damaged organ and hopefully achieve permanent replacement.
Scaffold materials are an indispensable part of tissue engineering, among which decellularized extracellular matrix (dECM) bio-materials [14,15] stand out because of their unique natural structure, biological induction activity and bio-compatibility. The dECM-based bio-materials are derived from an extracellular matrix and prepared using various decellularized methods [16]. It can not only provide a three-dimensional scaffold structure for tissue-regenerating cells but also regulate the behavior of these cells [17], including cell morphology, cell adhesion, cell proliferation, cell migration, cell differentiation and apoptosis. In addition, it can induce the proliferation and differentiation of stem cells in the host body and regulate cell signaling pathways and gene expression [18] through mechanical perception or receptor-mediated regulation. There are two types of application strategies used for a dECM. The first one is to directly apply a dECM [19,20] with or without drug molecules, bio-active agents and stem cells to fabricate bio-materials. The purpose is either to promote the recellularization progress [21] of pivotal stem cells in the host body and wait for them to fulfill their mission of differentiating and repairing or to re-perfuse the key stem cells into the dECM, then transplant those as a whole in vivo [22], expecting them to already function from the very beginning. The other one is to see the dECM as the bio-environment for organoids construction [23] or the disease model [24] base for research and sifting drugs.
A treated dentin matrix (TDM) [25] is a special kind of decellularized extracellular matrix (dECM) that originates from a dentin matrix (DM). A TDM preserves the basic structure of natural dentinal tubules, allowing stem cells to adhere and providing the necessary space for nutrient and metabolic waste exchange. It also exposes various and abundant bio-active proteins [26], such as growth factors, to better induce stem cell proliferation, adhesion and differentiation to promote dental pulp, dentin, cementum, periodontal ligament and alveolar bone regeneration [27,28]. Furthermore, a TDM is able to serve as a carrier and release controller for some drug molecules [29,30,31] and bio-active agents [32,33,34] by taking advantage of its unique structure of exposed dentinal tubules. The above characteristics of a TDM have enabled it to become a promising dECM-based bio-material that is capable and worthy of applying to tissue regeneration and related immunomodulation. Although dentin-derived bio-materials have been constructed and explored for potential applications in clinical practice, there lacks a retrospective summary of the overall situation and a prospective discussion regarding future research. Therefore, this review briefly introduces the sources, the fabricating and preserving methods, and the vital properties of a TDM. More importantly, we summarized the applications in the tissue regeneration process and challenges facing future research regarding this promising bio-material.

2. The Origin of TDM—Dentin Matrix

Dentin composes the major bulk of tooth hard tissue and serves the functions of protecting dental pulp and supporting enamel. It contains 70% mineral phase; 18% collagen; 2% non-collagenous proteins (NCPs), such as dentin matrix protein-1 (DMP-1), dentin sialoprotein (DSP) and dentinphosphoproteins (DPP); and 10% water [35,36]. The dentin matrix possesses abundant growth factors [33], such as basic fibroblast growth factor, insulin-like growth factor, transforming growth factor β and bone morphogenetic proteins [35], and resembles the bone matrix [26]. In carious circumstances of demineralization, bacteria-produced acid would resolve hydroxylapatite of the dentin matrix, resulting in a loss of highly mineralized particles and degradation of the collagen matrix. However, inspired by the highly pathological process, precise control of the demineralization of dentin matrix acquired from extracted teeth would enable us to achieve the expected objectives of opening the dentinal tubules and releasing the bio-active agents while preserving a certain level of structural integrity and rigidity.

3. The Vital Properties of a TDM

3.1. Natural Porous Structure Is Preserved after a Fabrication Process and Shows Open Dentinal Tubules

An important property of a TDM is the porous structure, which is present after a serial preparation procedure. This unique natural structure showing exposed dentinal tubules (Figure 1) displays an average diameter of around 2–5 μm [31], which allows nanoscale drug molecules and exogenous bio-active agents to be immersed in and released into the surroundings later. Moreover, this structure supports the nutrient and metabolic waste exchange in the tissue regeneration micro-environment. A root-shaped TDM usually applies to bio-root construction with a 10 mm length and 1 mm thickness, whereas particle-shaped TDM for hydrogel or paste fabrication has a diameter ranging from less than 40 μm to 2 mm [35]. Furthermore, with the prolonging of demineralization time, a treated dentin matrix showed nanoscale fissures among opened dentinal tubules [31], which is also favorable for carrying drug molecules that are to be released later.

3.2. A Surface with Proper Hydrophilicity Is Favorable for Cell Adhesion

The proper hydrophilicity of the material’s surface enables either in vitro co-cultured stem cells or in vivo migrating cells to adhere and then proliferate and differentiate on it [30,31].

3.3. Odontogenic/Osteogenic-Related Proteins Are Preserved after a Serial Preparation and Are Similar to Those of a Native Dentin Matrix

A dentin matrix contains abundant collagen proteins [37]; non-collagen proteins, such as osteopontin, osteocalcin, dentin matrix protein, dentin phosphoprotein and dentin sialoprotein [38]; and growth factors, such as basic fibroblast growth factor, insulin-like growth factor and transforming growth factor β [35]. It also contains bone morphogenetic proteins (BMPs) [39]. The results of a shotgun proteomic strategy applied to profile human TDM proteome showed that collagens, proteoglycans, small integrin-binding ligand N-linked glycoproteins and growth factors were identified [40], which supplements the evidence showing that a TDM contains a similar protein composition to a native dentin matrix.

3.4. Treated Dentin Matrix and Its Derivatives Promote Cell Proliferation on Most Occasions (Table 1)

In most cases, a TDM and its derivatives display a positive effect on the viability and proliferation of co-cultured stem cells [41,42,43,44,45]. Contrarily yet interestingly, sometimes the derivants can display a suppressive or slightly inhibitive effect on cell proliferation [46,47]. Dental pulp stem cells (DPSCs) [41,42,43,44,45,46], odontoblast-like cell lines [42] and periodontal ligament stem cells (PDLSCs) [47] were employed to explore the effect of a treated dentin matrix on cell proliferation by means of an MTT assay, CCK8 assay or Ki-67 detection.
Table
Table 1. Treated dentin matrix and its derivatives’ effects on cell proliferation.
Table 1. Treated dentin matrix and its derivatives’ effects on cell proliferation.
Authors
Ref.		Type of CellMain Conclusion
Brunello et al.
[41]		DPSCBoth human dentin particulates and deproteinized bovine bone matrix supported cell proliferation equally well.
Salehi et al.
[42]		OD-21
MDPC-23		Dose-dependent promotion of cell proliferation with a higher concentration of the dentin matrix components was verified.
Horsophonphong et al.
[43]		OD-21Both human dentin matrix molecules and bovine dentin matrix molecules enhanced cell proliferation.
Chen et al.
[44]		DPSCTreated dentin matrix paste significantly promoted cell proliferation.
Kulakowski et al.
[45]		DPSCCells cultured with proanthocyanidin-treated dentin exhibited increased proliferation.
Wen et al.
[46]		DPSCTreated dentin matrix extracts combined with dental-pulp-cell-derived small extracellular vesicles suppressed cell proliferation.
Xiong et al.
[47]		PDLSCLiquid extracts of fresh/cryopreserved/freeze-dried demineralized dentin matrix slightly inhibited cell proliferation.
DPSC: dental pulp stem cell, PDLSC: periodontal ligament stem cell, OD-21: undifferentiated mouse dental pulp cells, MDPC-23: odontoblast-like cell line.

3.5. A Treated Dentin Matrix Possesses Osteogenic and Odontogenic Induction Activity (Table 2)

A TDM possesses the ability to induce a couple of mesenchymal stem cells to differentiate toward odontoblasts and osteoblasts. Induced mesenchymal cells can express more odontogenic- and osteogenic-related genes and proteins. Dental pulp stem cells (DPSCs) [33,44,45,48,49,50,51,52], dental follicle cells (DFCs) [27,51,52,53,54,55], cranial neural crest cells (CNCCs) [51], umbilical cord mesenchymal stem cells (UCMSCs) [56] and bone marrow stromal cells (BMSCs) [57] were employed to explore the effect of a treated dentin matrix on cell differentiation by means of polymerase chain reaction, Western blot assay or immunostaining.
Table
Table 2. Treated dentin matrix and its derivatives’ effects on cell differentiation.
Table 2. Treated dentin matrix and its derivatives’ effects on cell differentiation.
Authors
Ref.		Type of CellMain Conclusion
Bakhtiar et al.
[48]		DPSCDMP-1 and DSPP expressions of stem cells increased after treated dentin matrix induction.
Chang et al.
[49]		DPSCStem cells were positively stained for DSP and DMP1 in the autoclaved human-treated dentin matrix group.
Meng et al.
[50]		DPSCThe mRNA expressions of OCN, DSPP, VEGF-1 and Nestin in stem cells were obviously upregulated by a human-treated dentin matrix leaching solution.
Chen et al.
[44]		DPSCTreated dentin matrix paste significantly enhanced the expressions of ALP, BSP and DSP.
Melling et al.
[33]		DPSCDemineralized dentin matrix liposomes promoted the upregulation of OCN and RUNX2 in stem cells.
Kulakowski et al.
[45]		DPSCProanthocyanidin-treated dentin increased the expressions of RUNX2, BMP2, OCN and DSPP.
Jiao et al.
[53]		DFCA cryopreserved dentin matrix extract liquid induced stem cells to highly express BSP, COL-1 and ALP.
Yang et al.
[27]		DFCTreated dentin matrix induced stem cells to highly express DMP-1 and BSP.
Li et al.
[54]		DFCPorcine-treated dentin matrix can facilitate the odontoblast differentiation of stem cells.
Chen et al.
[51]		DFC, DPSC and CNCCWith the induction of a treated dentin matrix, DFCs displayed similar expression patterns of neurofilament, tubulin and nestin to DPCs. Meanwhile, DFCs showed more similar protein profiles of COL1, TGF-β1, OPN and DMP-1 to CNCCs than DPCs.
Zhang et al.
[56]		UCMSCLiquid extract of a human-treated dentin matrix induced stem cells to express DSPP, DMP-1 and DSP.
Yang et al.
[57]		BMSCHuman-treated dentin matrix particles promoted the osteogenic differentiation of stem cells.
Yang et al.
[55]		DFC and HERSCA treated dentin matrix’s presence and HERSCs’ induction enhanced the osteogenic differentiation of DFCs.
Guo et al.
[52]		DFC and DPCA treated dentin matrix induced both DFCs and DPCs to display odontogenic differentiation potential.
DPSC: dental pulp stem cell, DFC: dental follicle cell, CNCC: cranial neural crest cell, UCMSC: umbilical cord mesenchymal stem cell, BMSC: bone marrow stromal cell, HERSC: Hertwig’s epithelial root sheath cell.

4. Different Methods of Fabricating and Preserving TDM

The fabricating strategy for a TDM usually consists of the following basic steps: teeth extraction, cementum and dental pulp removal, section into matrixes or pulverization into particles, demineralization, special treatment (not always necessary), sterilization and preservation. Grawish et al. offered quite a detailed elaboration on the fabrication process and preservation choices of TDM [35]. Therefore, we intended to focus on some special and novel treatments to facilitate TDM construction or to inspire the improvements of TDM-based bio-material preparation.

4.1. Harvesting the Tooth Root from Different Species (Figure 2)

Extracted human teeth are the most common source for harvesting TDM raw material [43,46,49,50,56,57,58,59,60,61,62,63,64,65]. Experiments conducted with animal TDMs, such as bovine [43,48], canine [28], goat [49], monkey [28] and porcine TDMs [28,31,32,46,66,67,68], show that these are also feasible. It is worth noting that the porcine TDM possesses similar mineral phases, bioactive molecules and odontogenic induction ability to a human TDM [66].
Pharmaceutics 15 00091 g002 550
Figure 2. Animal origins of treated dentin matrixes.
Figure 2. Animal origins of treated dentin matrixes.
Pharmaceutics 15 00091 g002

4.2. Special Treatment Procedures (Table 3)

Other than the basic procedures (Figure 3), novel treatments of TDM in various experiments were conducted to explore the possibilities for realizing the goals of decreasing inflammatory responses [48] and promoting dentin–pulp regeneration [58,69]. In addition, some treatment methods for demineralized dentin matrixes are provided as inspiration and references for enhancing the mechanical [59,60] and biological [61] properties of TDMs for use in clinical practices.
Table
Table 3. Special treatments of treated dentin matrixes during the preparation procedure.
Table 3. Special treatments of treated dentin matrixes during the preparation procedure.
Authors
Ref.		Special TreatmentMain Conclusion
Bakhtiar et al.
[48]		Atelopeptidization with pepsinAtelopeptidization of demineralized dentin could facilitate preserving collagen structure and reducing the immune reaction.
Li et al.
[59]		Ethanol/DMATreatment using DMA/ethanol solution might be capable of enhancing the mechanical properties of a demineralized dentin matrix.
Omar et al.
[60]		Plant-based polyphenolsPB-Ps reduced the degradation of dentin extracellular matrixes and improved the apparent elastic modulus.
Okamoto et al.
[61]		MMPsDentin matrix components partially digested by matrix metalloproteinases, especially MMP-20, stimulated tertiary dentin formation in vivo and indicated its potential for wound healing of the dentin–pulp complex.
Wang et al.
[69]		FreezingA freeze-dried dentin matrix has similar mechanical and biological properties to those of dentin.
Li et al.
[58]		Different grinding speedsAn LTDM induced a twice greater expression of DSPP and DMP-1 in stem cells than an HTDM, while an HTDM induced a twice greater expression of BSP in stem cells than an LTDM. Neo-dentin formed on the inner surface of an LTDM and neo-cementum formed on the outer surface of an HTDM.
DMA: N-(3,4-dihydroxyphenethyl)methacrylamide, PB-Ps: plant-based polyphenols, MMPs: matrix metalloproteinases, LTDM: low-speed hTDM with a maximum speed of 500 rpm, HTDM: high-speed hTDM with a speed of 380,000 rpm.

5. TDM Applications

To date, treated dentin matrixes and their derivatives are being employed in the field of tissue regeneration studies, including dental pulp/dentin/dentin–pulp complex regeneration, periodontal tissue regeneration, bone regeneration, bio-root construction and drug delivery system for immunomodulation and regeneration processes.

5.1. Dental Pulp/Dentin/Dentin–Pulp Complex Regeneration (Table 4)

Dental pulp is a connective tissue that contains nerves and vessels inside the chamber formed by dentin and enamel. The objective of dental pulp regeneration refers to vascularized soft tissue with dispersed nerves, orderly odontoblasts contributing peripherally and dentin-like mineralized tissues. Histological detection methods, such as hematoxylin and eosin (H&E) staining, Masson’s trichrome staining and immunostaining are commonly applied to verify the genuine repair outcome. Imaging tests, such as X-rays, cone-beam computed tomography (CBCT) and micro-CT, are employed to examine hard tissue formation. Clinical examinations via the electric pulp test and color Doppler flow imaging (CDFI) are used to evaluate the vitality of pulp tissue. Dental pulp stem cells (DPSCs) [33,49,69,70,71,72]; dental follicle cells (DFCs) [53,65]; and related products [73,74], such as hydrogel [75,76,77], paste [44] and a mixed complex of TDM particles with stem-cell-derived small extracellular vesicles [46], were employed to explore the dental pulp/dentin/dentin–pulp regeneration effect of a TDM or its derivatives.
Table
Table 4. Treated dentin matrix and its derivatives for dentin/pulp/dentin–pulp regeneration.
Table 4. Treated dentin matrix and its derivatives for dentin/pulp/dentin–pulp regeneration.
Authors
Ref.		Major Composition of the Bio-MaterialMain Conclusion
Chang et al.
[49]		Allogenous autoclaved TDM + DPSCsAn allogenous autoclaved treated dentin matrix induced stem cells to develop new dentin pulp-like tissues, dental pulp and cementum periodontal complexes. DSP, βⅢ-tubulin, DMP-1, COL-1 and CAP were positive in toothlike tissue.
Liu et al.
[70]		TDM + DPSCsNew dentin was found in a rat mandible cultured with a treated dentin matrix and was significantly thicker.
Tran et al.
[71]		TD + DPSCsTreated dentin induced stem cells to regenerate dentin-like tissues that expressed DSPP and DMP-1.
Melling et al.
[33]		DDM + DPSCsDemineralized dentin matrix liposomes increased stem cells’ mineralization.
Wang et al.
[69]		FDDM + DPSCsA freeze-derived dentin matrix supported dentin-pulp-like tissue regeneration, which was positively stained with DSP and ALP.
Liu et al.
[72]		DDM + DPSCsA demineralized dentin matrix could induce DPSC to form mineralized tissue, which was stained positive for DSPP.
Jiao et al.
[53]		CDM + DFCsA cryopreserved dentin matrix could induce stem cells to regenerate new dentin-pulp-like tissues, including dentinal tubules, predentin, collagen fibers, nerves and blood vessels, which were positive for DSPP, DMP-1, tubulin and COL-1.
Li et al.
[65]		TDM + DFCsA human-treated dentin matrix induced complete dentin tissue regeneration that expressed DSP and DMP-1.
Holiel et al.
[75,76]		TDMHA treated dentin matrix hydrogel was developed for direct pulp capping. It could contribute to achieving dentin regeneration and conservation of pulp vitality.
CBCT showed TDMH-induced superior dentin bridge formation of higher radiodensity and thickness than Biodentine and MTA.
Histological analysis showed TDMH induced thicker dentin with layers of well-arranged odontoblasts than Biodentine and MTA.
Chen et al.
[44]		TDMPA treated dentin matrix paste was developed for pulp capping. TDMP induced the formation of a continuous reparative dentin bridge that was thicker and denser than calcium hydroxide. TDMP achieved both dentin regeneration and vital pulp conservation.
Wen et al.
[46]		sEV-TDMsEV-TDM was developed by combining treated dentin matrix proteins and dental-pulp-cell-derived small extracellular vesicles. It was testified that sEV-TDM promoted the formation of continuous reparative dentin. Odontoblast-like high columnar cells were observed on the pulp side of the dentin bridge.
Cunha et al.
[77]		DMMA microparticulate hydrogel supplemented with dentin matrix molecules was developed for dental pulp capping. A microgel + DMM induced more dentin bridge formation and less pulp necrosis than MTA.
Fu et al.
[73]		TDM + DPEMTreated dentin matrix combined with a laminin-modified dental pulp extracellular matrix promoted odontogenic differentiation of cells and dental pulp regeneration as shown by the expression of DMP-1 and DSPP and a continuous odontoblastic layer-like structure.
Na et al.
[74]		TDMF + CSDP + CSHuman-treated dentine matrix fragments combined with a cell sheet and stem-cell sheet-derived pellet induced highly vascularized dental-pulp-like tissue with odontoblast-like cells expressing DSPP, ALP and BSP.

5.2. Periodontal Tissue Regeneration (Table 5)

Periodontal tissues include cementum, periodontal ligament, alveolar bone and gingiva. Together, they serve the functions of supporting teeth and rendering the steadiness of teeth. To accomplish the goal of periodontal tissue regeneration, a sandwich structure of cementum-like tissue, bone tissue formation and orderly arrangement of fibers with two ends respectively embedded in cementum-like tissue and buccal bone tissue, resembling Sharpey’s fibers, is required [78]. HE staining, Masson staining and immunostaining are commonly used to verify the fiber and mineralized tissue formation. Imaging tests, such as cone-beam computed tomography (CBCT) and micro-CT are mainly conducted to display the alveolar bone tissue formation outcome. Clinical examinations via the tooth mobility test and probing test are applied to evaluate the healthiness of periodontal tissue. Dental pulp stem cells (DPSCs) [49], dental follicle cells (DFCs) [57,79], stem cells from human exfoliated deciduous teeth (SHEDs) [79] and related products [63,80] were employed to explore the periodontal tissue regeneration effect of TDM or its derivatives.
Table
Table 5. Treated dentin matrix and its derivatives for periodontal tissue regeneration.
Table 5. Treated dentin matrix and its derivatives for periodontal tissue regeneration.
Authors
Ref.		Major Composition of the Bio-MaterialMain Conclusion
Chang et al.
[49]		Allogenous autoclaved-TDM + DPSCsAn allogenous autoclaved treated dentin matrix induced stem cells to develop cementum periodontal complexes, where COL-1- and CAP-positive stains were produced.
Yang et al.
[57]		TDMPs + DFC cell sheetsHuman treated dentin matrix particles combined with stem cell sheets induced new bone formation and periodontal-like tissues in animal experiments.
Li et al.
[63]		DDM granulesDemineralized dentin matrix granules prepared at the chairside after extractions showed no significant difference in implant stability quotient values and marginal bone resorption when being applied to guided bone regeneration for immediate implantation in periodontal postextraction sites compared with Bio-Oss.
Yang et al.
[79]		TDM + DFC
TDM + SHED		Treated dentin matrix combined with either DFC or SHED successfully achieved periodontal tissue regeneration, showing periodontal ligament fibers, blood vessels and newly created alveolar bone.
Ji et al.
[80]		TDM + PRFA treated dentin matrix combined with autologous platelet-rich fibrin induced cementum and periodontal ligament (PDL)-like tissue regeneration.

5.3. Bio-Root Construction (Table 6)

TDM-based bio-root construction has not only achieved the histological goal of tissue regeneration regarding pulp, dentin, cementum, periodontal ligament and alveolar bone but has also realized the superior objective of bio-functioning [28], specifically load-bearing masticatory movement [54,81]. Dental pulp stem cells (DPSCs) [50], dental follicle cells (DFCs) [27,28,29,30,31,32,54,66,82], adipose-derived stromal/stem cells (ASCs) [67] and related products [68] were employed to explore the potential of constructing bio-root (Figure 4) out of TDM or its derivatives. The porous structure of a treated dentin matrix has enabled it to become a promising bio-material as a drug carrier and delivery system. The molecules with or without capsule modifications can be detached to the surface or into the tubule chamber of TDM, which are later released from the substance. During research work on bio-root construction, immunological rejection caused by xenograft [30,31,66,83], oxidative stress injury and infection is an inevitably encountered challenge; it could be worth making attempts to load drug molecules of immune response regulators [30,31], antioxidants [29,32], antibiotics [84] and bio-active agents [28,34] for the purpose of achieving better bio-root regeneration.
Table
Table 6. Treated dentin matrix and its derivatives for bio-root construction.
Table 6. Treated dentin matrix and its derivatives for bio-root construction.
Authors
Ref.		Major Composition of the Bio-MaterialMain Conclusion
Meng et al.
[50]		TDM + Matrigel + DPSC sheetA treated dentin matrix/Matrigel/DPSC sheet complex was fabricated for promoting periodontium, dentin and pulp-like tissue regeneration. Periodontium-like dense connective tissue, predentin, odontoblast-like cells, blood vessel-like structures and even nerve-like fibers were observed.
Li et al.
[66]		pTDM + DFCA porcine treated dentin matrix induced odontogenesis as observed by the production of pre-dentin, cementum, collagen fibrils, odontoblast-like cells and fibroblasts, even though the xenogeneic implants inevitably initiated Th1 inflammation.
Zhang et al.
[29]		TDM + DFC + NACA treated dentin matrix loaded with antioxidant NAC decreased HO-induced cellular damage, maintained DFCs’ odontogenic differentiation potential and repressed replacement resorption or ankylosis, thus facilitating bio-root regeneration.
Sun et al.
[32]		TDM + DFC + tBHQThe scaffold of a tBHQ-treated xenogenic treated dentin matrix with DFCs implanted in vivo showed reduced osteolysis and osteoclastic resorption.
Yang et al.
[27]		TDM + DFCA treated dentin matrix induced DFCs to develop new dentin–pulp-like tissues and cementum–periodontal complexes.
Guo et al.
[82]		TDM + DFCA treated dentin matrix induced DFCs to form root-like tissues that were stained positive for markers of dental pulp and periodontal tissues.
Li et al.
[54]		TDM + DFCA porcine treated dentin matrix combined with DFCs was transplanted into the jaws of rhesus monkeys. Periodontal ligament-like fibers accompanied by macrophage polarization, fibroblasts and blood vessels were observed. Meanwhile, the constructed bio-root possessed biomechanical properties that could endure masticatory forces.
Guo et al.
[52]		TDM + DFC/DPCA treated dentin matrix induced both DFCs and DPCs to form pulp–dentin/cementum–periodentium-like tissues.
Chen et al.
[28]		TDM + DFC + BMP4 + TGF-β1A treated dentin matrix combined with TGF-β1, BMP4 and DFCs embodied a spatial interface gradient for functional enthesis formation to promote functional bio-root regeneration. Effectively functional bio-roots made of the composites were successfully constructed, with the presentation of outstanding biomechanical properties and healthy gingiva.
Luo et al.
[81]		CAD- and FEA-based shape-optimized TDMComputer-aided design and finite element analysis were used to create shape-optimized treated dentin matrix combined with stem cells that successfully achieved root regeneration and a stable performance of masticatory function.
Yuan et al.
[67]		TDM + ASCA porcine treated dentin matrix induced ASC to differentiate toward odontogenesis and promoted dentin-like tissue, pulp-like tissue and periodontal-fiber-like tissue regeneration.
Chen et al.
[68]		TDM + APES + DPEMA treated dentin matrix combined with an aligned PLGA/gelatin electrospun sheet and dental pulp extracellular matrix promoted pulp–dentin complex-like tissues and periodontium-complex-like tissue regeneration, presenting columnar odontoblast-like cells, newly formed predentin, blood vessels, cellular cementum and periodontal ligament (PDL)-like tissues.
Han et al.
[31]		NDM + RSGA native decellularized matrix made of treated dentin matrix loaded with RSG decreased the expression of IL-1 and TNF-α, increased the expression of IL-10 and TGF-β, induced M2 macrophages to antagonize M1 macrophages using PPARγ, created favorable immunomodulation and promoted ligament-to-bone regeneration.
Lan et al.
[30]		ECM + RSGExtracellular matrix made of treated dentin matrix loaded with RSG activated PPAR-γ downregulated the expression of proinflammatory NOS2 + M1 macrophages and ROS to facilitate bio-root regeneration.
Li et al.
[83]		TDM + PPARγ-primed CD68CD206 M2 phenotypeA treated dentin matrix combined with PPARγ-primed CD68CD206 M2 phenotype alleviated proinflammatory cytokines (TNF-α, IFN-γ) at the inflammation site; decreased CD3CD8 T lymphocytes in the periphery system; immunosuppressed IL-1β, IL-6, TNF-α and MMPs; enabled xenograft escape immune rejection; and promoted a xenogenic bio-root to survive in the host.
NAC: N-acetylcysteine, tBHQ: tert-butylhydroquinone, TGF-β1: transforming growth factor beta 1, BMP4: bone morphogenetic protein 4, CAD: computer-aided design, FEA: finite element analysis, RSG: Rosiglitazone, PPAR-γ: peroxisome proliferators receptor γ, ROS: reactive oxygen species.

5.4. Bone Regeneration (Table 7)

Treated-dentin-matrix-based bio-material’s application in bone tissue regeneration mainly focuses on alveolar ridge preservation and socket preservation after extraction [62,64,85,86,87]. HE staining, Masson staining and immunostaining are commonly used to verify the mineralized tissue formation. Imaging tests, such as cone-beam computed tomography (CBCT) and micro-CT, are mainly conducted to display the alveolar bone tissue formation outcome.
Table
Table 7. Treated dentin matrix and its derivatives for bone regeneration.
Table 7. Treated dentin matrix and its derivatives for bone regeneration.
Authors
Ref.		Major CompositionMain Conclusion
Moraes et al.
[85]		DHDMDemineralized human dentine matrix contributed to alveolar ridge preservation, as testified by microtomography and histological evaluation showing new bone formation with the slow reabsorption of DHDM.
Li et al.
[86]		ADDMAutogenous demineralized dentin matrix exhibited osteogenic effectiveness in bone augmentation, just as Bio-Oss® did for oral bone defects.
Murata et al.
[62]		pDDMPartially demineralized dentin/cementum matrix contributed to socket preservation as shown by bone-like radio-opacity in the graft region and newly formed bone connected directly with dentin/cementum area.
Um et al.
[87]		aDDMAutogenous demineralized dentin matrix loaded with recombinant human bone morphogenetic 2 contributed to socket preservation. BMP-2 enhanced bone formation effectiveness.
Reis-Filho et al.
[64]		DHDMA human demineralized dentine matrix has the potential for osteogenic induction and increases bone tissue formation and vessel tissue formation in sockets.

6. Future Perspectives

6.1. Underlying Mechanism

Despite the fact that there has been a lot of research aimed at application exploration and induction ability confirmation, only very few studies have paid attention to the underlying mechanisms [70]. In this case, it might hinder us from digging more deeply for knowledge of TDMs’ biological induction abilities. Therefore, in-depth studies about mechanisms are needed.

6.2. Expanding Sources

In most cases, we employ the intact teeth without any pathological condition for TDM fabrication and apply it to tissue regeneration. However, we must not ignore the huge potential for extracted teeth subjected to dental diseases, such as caries and periodontitis. It is worth conducting experiments to examine the physical properties and biological abilities after the same fabricating procedure (with and without the action of removing the obvious lesion) to explore and expand the sources that are already regarded as medical waste yet possess great possibilities for recycling.
In order to further expand the source of TDM raw materials, animal teeth are eligible and cost-efficient to be taken into consideration for massive production. This indeed puts forward serious concerns about the similarities between an animal TDM and human TDM and xenogeneic-substance-related immune response regulation. Porcine TDM was already testified to possess similar mineral phases and bio-active molecules to a human TDM [66]. Immunomodulation-related drugs are also being investigated regarding alleviating the immune response of xenogeneic TDM transplantation and facilitating bio-root tissue regeneration and functional stability [30,31]. It is necessary to continue launching experiments to compare the TDM properties between more species. Meanwhile, it is also very important to carry out studies on immunomodulation to create a xenogeneic-friendly micro-environment for a xenogenous bio-root to survive.

6.3. Three-Dimensional Construction for Individual Customization in Clinical Application

When it comes to clinical application, the shape and size of damaged tissue vary from patient to patient. Therefore, in order to obtain a precise match between transplantation and the defective tissue region, three-dimensional bio-printing is available. A TDM particle can be pulverized into micron-order particles and mixed into the bio-ink of a 3D bio-printer to harvest the best morphological match and achieve an individualized repair goal [88].

6.4. Taking Better Advantage of the Natural Porous Structure for Drug Delivery

Last but not the least, the naturally porous structure of open dentinal tubules are showing great potential for drug delivery, yet is only moderately being taken advantage of. On the one hand, the porous structure of the material and the collagen fibers exposed by decellularization also provide the material basis for drug delivery [31]. On the other hand, there are many active groups on the surface of a treated dentin matrix that also provide favorable conditions for drug loading [54].
In addition, considering that drug molecules delivered by bio-materials are always applied to tissue regeneration with a combination of stem cells, it is also of necessity and importance to notice the interactions between the nanoparticles and the vital cells in the biological environment to achieve a favorable therapeutic effect. Specifically speaking, in the research fields of root canal sealing agents application [89], periodontal tissue regeneration [90] and endodontic disease treatment [91], studies concluded that most of the drug delivery systems provide a micro-environment for tissue remineralization while also displaying a beneficial effect on coupling stem cells, avoiding cytotoxic disadvantages and offering benign biocompatibility, which the treated dentin matrix can also achieve.
Moreover, proteins in blood and tissue fluid would be adsorbed onto the surface of the material to form a protein layer within a few nanoseconds of contacting the bio-material. This protein layer constitutes a temporary structure that recruits inflammatory-response-related cells and initiates the acute immune inflammatory response [92]. Likewise, a protein-rich layer called the “protein corona” coating on the nanoparticles’ surface would form after interaction with the surrounding biological environment [93]. In order to achieve the goal of balancing the immune responses and constructing a micro-environment that is favorable for promoting tissue regeneration, the characteristics and regulating strategies of these two structures of the protein layer are not to be neglected.
To date, there are only a few studies that reported a TDM carrying anti-oxidant or immunomodulation drugs [29,30,31] and bio-active agents [32,33,34] via a very rigid loading strategy of just soaking a TDM into the drug solution. Therefore, in the future, more studies of drug molecules or bio-active agents carried by a TDM with or without bio-modification are needed to explore the effects of themselves and TDM delivery efficiency during the regeneration process. Furthermore, the methods of loading molecules and agents into or onto the scaffold should be modified and innovated.

7. Conclusions

A TDM serves as a promising candidate for bio-root construction due to its natural characteristic of being able to induce dental pulp cells to differentiate into odontoblasts and form dentin-like tissues, as well as to induce dental follicle cells to differentiate into cementoblasts, fibroblasts and osteoblasts to form cementum-like tissues, periodontal-ligament-like fibers and bone tissues. In the meantime, a TDM can also be ground and sifted to micro-sized particles and mixed with other materials to become bio-ink for 3D printing, pulp capping agent and osteoinduction supplements. Other than the abovementioned, TDM extracts are also highly bio-active and osteoinductive agents that can be applied to tissue repair [43,61]. What is noteworthy is that the application of TDM will not be restricted to the field of just dental research. Thanks to the unique porous structure and growth factors preserved within, a TDM is able to play a role in bone regeneration, soft–hard tissue interface reconstruction and immunomodulation with its own endogenous bio-active molecules and carried exogenous drugs [29,30,31,32]. Furthermore, the sources of TDM include homogenous human teeth extracted due to orthodontics needs and heterogenous extracted animal teeth from wasted jawbones, which are sufficient and ethically friendly.
Thus, it is necessary to provide a more solid theoretical basis for tissue regeneration by taking advantage of TDM by performing deeper probation into all levels of mechanisms from molecules to tissues, from signaling pathways to function performances and from micro-environment to structural construction. Additionally, it is urgently needed to put forward serious challenges facing clinical translational application to impel researchers to contribute realistically to constructing genuinely useful clinical practice that is beneficial to humankind.
In summary, a treated dentin matrix not only plays an important role in tooth and periodontal repair but also has the potential to promote other tissue regeneration. Despite the fact that considerable work has been done in the field, specific regeneration processes, underlying mechanisms and clinical application possibilities still need to be further explored and illustrated.

Author Contributions

Original draft, F.B. and Z.Z.; review and revision, F.B., Z.Z. and W.G.; conception, F.B. and W.G. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The relevant data is contained within this review.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. James, S.L.; Abate, D.; Abate, K.H.; Abay, S.M.; Abbafati, C.; Abbasi, N.; Abbastabar, H.; Abd-Allah, F.; Abdela, J.; Abdelalim, A.; et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018, 392, 1789–1858. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Alvarez, E.M.; Force, L.M.; Xu, R.; Compton, K.; Lu, D.; Henrikson, H.J.; Kocarnik, J.M.; Harvey, J.D.; Pennini, A.; Dean, F.E.; et al. The global burden of adolescent and young adult cancer in 2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Oncol. 2022, 23, 27–52. [Google Scholar] [CrossRef] [PubMed]
  3. Murray, C.J.; Ikuta, K.S.; Sharara, F.; Swetschinski, L.; Aguilar, G.R.; Gray, A.; Han, C.; Bisignano, C.; Rao, P.; Wool, E.; et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 2022, 399, 629–655. [Google Scholar] [CrossRef] [PubMed]
  4. Murray, C. The Global Burden of Disease Study at 30 years. Nat. Med. 2022, 28, 2019–2026. [Google Scholar] [CrossRef]
  5. Ahmed, M.; Rubio, I.T.; Klaase, J.M.; Douek, M. Surgical treatment of nonpalpable primary invasive and in situ breast cancer. Nat. Rev. Clin. Oncol. 2015, 12, 645–663. [Google Scholar] [CrossRef]
  6. Saranga-Perry, V.; Ambe, C.; Zager, J.S.; Kudchadkar, R.R. Recent developments in the medical and surgical treatment of melanoma. CA Cancer J. Clin. 2014, 64, 171–185. [Google Scholar] [CrossRef]
  7. Kempker, R.R.; Vashakidze, S.; Solomonia, N.; Dzidzikashvili, N.; Blumberg, H.M. Surgical treatment of drug-resistant tuberculosis. Lancet Infect. Dis. 2012, 12, 157–166. [Google Scholar] [CrossRef] [Green Version]
  8. Arfaee, M.; Vis, A.; Kluin, J. Future technologies in total artificial heart development: Can a robot become as good as a donor heart? Eur. Heart J. 2022, 43, 4970–4972. [Google Scholar] [CrossRef]
  9. Dangas, G.D.; Weitz, J.I.; Giustino, G.; Makkar, R.; Mehran, R. Prosthetic Heart Valve Thrombosis. J. Am. Coll. Cardiol. 2016, 68, 2670–2689. [Google Scholar] [CrossRef]
  10. Hockel, M.; Dornhofer, N. Vulvovaginal reconstruction for neoplastic disease. Lancet Oncol. 2008, 9, 559–568. [Google Scholar] [CrossRef]
  11. Guo, S.; Han, Y.; Zhang, X.; Lu, B.; Yi, C.; Zhang, H.; Ma, X.; Wang, D.; Yang, L.; Fan, X.; et al. Human facial allotransplantation: A 2-year follow-up study. Lancet 2008, 372, 631–638. [Google Scholar] [CrossRef] [PubMed]
  12. Griffith, B.P.; Goerlich, C.E.; Singh, A.K.; Rothblatt, M.; Lau, C.L.; Shah, A.; Lorber, M.; Grazioli, A.; Saharia, K.K.; Hong, S.N.; et al. Genetically Modified Porcine-to-Human Cardiac Xenotransplantation. N. Engl. J. Med. 2022, 387, 35–44. [Google Scholar] [CrossRef] [PubMed]
  13. Zhao, Y.; Song, S.; Ren, X.; Zhang, J.; Lin, Q.; Zhao, Y. Supramolecular Adhesive Hydrogels for Tissue Engineering Applications. Chem. Rev. 2022, 122, 5604–5640. [Google Scholar] [CrossRef] [PubMed]
  14. Kim, B.S.; Das, S.; Jang, J.; Cho, D.W. Decellularized Extracellular Matrix-based Bioinks for Engineering Tissue- and Organ-specific Microenvironments. Chem. Rev. 2020, 120, 10608–10661. [Google Scholar] [CrossRef] [PubMed]
  15. De Santis, M.M.; Alsafadi, H.N.; Tas, S.; Bolukbas, D.A.; Prithiviraj, S.; Da, S.I.; Mittendorfer, M.; Ota, C.; Stegmayr, J.; Daoud, F.; et al. Extracellular-Matrix-Reinforced Bioinks for 3D Bioprinting Human Tissue. Adv. Mater. 2021, 33, e2005476. [Google Scholar] [CrossRef]
  16. Brown, M.; Li, J.; Moraes, C.; Tabrizian, M.; Li-Jessen, N. Decellularized extracellular matrix: New promising and challenging biomaterials for regenerative medicine. Biomaterials 2022, 289, 121786. [Google Scholar] [CrossRef]
  17. Neishabouri, A.; Soltani, K.A.; Daghigh, F.; Kajbafzadeh, A.M.; Majidi, Z.M. Decellularization in Tissue Engineering and Regenerative Medicine: Evaluation, Modification, and Application Methods. Front. Bioeng. Biotechnol. 2022, 10, 805299. [Google Scholar] [CrossRef]
  18. Wang, X.; Ma, Y.; Chen, J.; Liu, Y.; Liu, G.; Wang, P.; Wang, B.; Taketo, M.M.; Bellido, T.; Tu, X. A novel decellularized matrix of Wnt signaling-activated osteocytes accelerates the repair of critical-sized parietal bone defects with osteoclastogenesis, angiogenesis, and neurogenesis. Bioact. Mater. 2023, 21, 110–128. [Google Scholar] [CrossRef]
  19. Philips, C.; Terrie, L.; Thorrez, L. Decellularized skeletal muscle: A versatile biomaterial in tissue engineering and regenerative medicine. Biomaterials 2022, 283, 121436. [Google Scholar] [CrossRef]
  20. Song, J.J.; Ott, H.C. Organ engineering based on decellularized matrix scaffolds. Trends Mol. Med. 2011, 17, 424–432. [Google Scholar] [CrossRef]
  21. Barthold, J.E.; Martin, B.M.; Sridhar, S.L.; Vernerey, F.; Schneider, S.E.; Wacquez, A.; Ferguson, V.; Calve, S.; Neu, C.P. Recellularization and Integration of Dense Extracellular Matrix by Percolation of Tissue Microparticles. Adv. Funct. Mater. 2021, 31, 2103355. [Google Scholar] [CrossRef] [PubMed]
  22. Ohata, K.; Ott, H.C. Human-scale lung regeneration based on decellularized matrix scaffolds as a biologic platform. Surg. Today 2020, 50, 633–643. [Google Scholar] [CrossRef] [PubMed]
  23. Kim, S.; Min, S.; Choi, Y.S.; Jo, S.H.; Jung, J.H.; Han, K.; Kim, J.; An, S.; Ji, Y.W.; Kim, Y.G.; et al. Tissue extracellular matrix hydrogels as alternatives to Matrigel for culturing gastrointestinal organoids. Nat. Commun. 2022, 13, 1692. [Google Scholar] [CrossRef] [PubMed]
  24. Sensi, F.; D’Angelo, E.; Biccari, A.; Marangio, A.; Battisti, G.; Crotti, S.; Fassan, M.; Laterza, C.; Giomo, M.; Elvassore, N.; et al. Establishment of a human 3D pancreatic adenocarcinoma model based on a patient-derived extracellular matrix scaffold. Transl. Res. 2022. [Google Scholar] [CrossRef]
  25. Guo, W.; He, Y.; Zhang, X.; Lu, W.; Wang, C.; Yu, H.; Liu, Y.; Li, Y.; Zhou, Y.; Zhou, J.; et al. The use of dentin matrix scaffold and dental follicle cells for dentin regeneration. Biomaterials 2009, 30, 6708–6723. [Google Scholar] [CrossRef] [PubMed]
  26. Tabatabaei, F.S.; Tatari, S.; Samadi, R.; Torshabi, M. Surface characterization and biological properties of regular dentin, demineralized dentin, and deproteinized dentin. J. Mater. Sci. Mater. Med. 2016, 27, 164. [Google Scholar] [CrossRef]
  27. Yang, B.; Chen, G.; Li, J.; Zou, Q.; Xie, D.; Chen, Y.; Wang, H.; Zheng, X.; Long, J.; Tang, W.; et al. Tooth root regeneration using dental follicle cell sheets in combination with a dentin matrix-based scaffold. Biomaterials 2012, 33, 2449–2461. [Google Scholar] [CrossRef]
  28. Chen, J.; Liao, L.; Lan, T.; Zhang, Z.; Gai, K.; Huang, Y.; Chen, J.; Tian, W.; Guo, W. Treated dentin matrix-based scaffolds carrying TGF-β1/BMP4 for functional bio-root regeneration. Appl. Mater. Today 2020, 20, 100742. [Google Scholar] [CrossRef]
  29. Zhang, J.; Lan, T.; Han, X.; Xu, Y.; Liao, L.; Xie, L.; Yang, B.; Tian, W.; Guo, W. Improvement of ECM-based bioroot regeneration via N-acetylcysteine-induced antioxidative effects. Stem Cell Res. Ther. 2021, 12, 202. [Google Scholar] [CrossRef]
  30. Lan, T.; Chen, J.; Zhang, J.; Huo, F.; Han, X.; Zhang, Z.; Xu, Y.; Huang, Y.; Liao, L.; Xie, L.; et al. Xenoextracellular matrix-rosiglitazone complex-mediated immune evasion promotes xenogenic bioengineered root regeneration by altering M1/M2 macrophage polarization. Biomaterials 2021, 276, 121066. [Google Scholar] [CrossRef]
  31. Han, X.; Liao, L.; Zhu, T.; Xu, Y.; Bi, F.; Xie, L.; Li, H.; Huo, F.; Tian, W.; Guo, W. Xenogeneic native decellularized matrix carrying PPARgamma activator RSG regulating macrophage polarization to promote ligament-to-bone regeneration. Mater. Sci. Eng. C Mater. Biol. Appl. 2020, 116, 111224. [Google Scholar] [CrossRef] [PubMed]
  32. Sun, J.; Li, J.; Li, H.; Yang, H.; Chen, J.; Yang, B.; Huo, F.; Guo, W.; Tian, W. tBHQ Suppresses Osteoclastic Resorption in Xenogeneic-Treated Dentin Matrix-Based Scaffolds. Adv. Healthc. Mater. 2017, 6, 1700127. [Google Scholar] [CrossRef]
  33. Melling, G.E.; Colombo, J.S.; Avery, S.J.; Ayre, W.N.; Evans, S.L.; Waddington, R.J.; Sloan, A.J. Liposomal Delivery of Demineralized Dentin Matrix for Dental Tissue Regeneration. Tissue Eng. Part A 2018, 24, 1057–1065. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Jing, X.; Xie, B.; Li, X.; Dai, Y.; Nie, L.; Li, C. Peptide decorated demineralized dentin matrix with enhanced bioactivity, osteogenic differentiation via carboxymethyl chitosan. Dent. Mater. 2021, 37, 19–29. [Google Scholar] [CrossRef] [PubMed]
  35. Grawish, M.E.; Grawish, L.M.; Grawish, H.M.; Grawish, M.M.; Holiel, A.A.; Sultan, N.; El-Negoly, S.A. Demineralized Dentin Matrix for Dental and Alveolar Bone Tissues Regeneration: An Innovative Scope Review. Tissue Eng. Regen. Med. 2022, 19, 687–701. [Google Scholar] [CrossRef]
  36. Um, I.W.; Kim, Y.K.; Mitsugi, M. Demineralized dentin matrix scaffolds for alveolar bone engineering. J. Indian Prosthodont. Soc. 2017, 17, 120–127. [Google Scholar] [CrossRef] [PubMed]
  37. Chun, S.Y.; Lee, H.J.; Choi, Y.A.; Kim, K.M.; Baek, S.H.; Park, H.S.; Kim, J.Y.; Ahn, J.M.; Cho, J.Y.; Cho, D.W.; et al. Analysis of the soluble human tooth proteome and its ability to induce dentin/tooth regeneration. Tissue Eng. Part A 2011, 17, 181–191. [Google Scholar] [CrossRef]
  38. Ravindran, S.; George, A. Dentin Matrix Proteins in Bone Tissue Engineering. Adv. Exp. Med. Biol. 2015, 881, 129–142. [Google Scholar] [CrossRef] [Green Version]
  39. Murata, M.; Nezu, T.; Takebe, H.; Hirose, Y.; Okubo, N.; Saito, T.; Akazawa, T. Human dentin materials for minimally invasive bone regeneration: Animal studies and clinical cases. J. Oral Biosci. 2022. [Google Scholar] [CrossRef]
  40. Li, J.; Yang, H.; Lu, Q.; Chen, D.; Zhou, M.; Kuang, Y.; Ying, S.; Song, J. Proteomics and N-glycoproteomics analysis of an extracellular matrix-based scaffold-human treated dentin matrix. J. Tissue Eng. Regen. Med. 2019, 13, 1164–1177. [Google Scholar] [CrossRef] [PubMed]
  41. Brunello, G.; Zanotti, F.; Scortecci, G.; Sapoznikov, L.; Sivolella, S.; Zavan, B. Dentin Particulate for Bone Regeneration: An In Vitro Study. Int. J. Mol. Sci. 2022, 23, 9283. [Google Scholar] [CrossRef] [PubMed]
  42. Salehi, S.; Cooper, P.; Smith, A.; Ferracane, J. Dentin matrix components extracted with phosphoric acid enhance cell proliferation and mineralization. Dent. Mater. 2016, 32, 334–342. [Google Scholar] [CrossRef] [PubMed]
  43. Horsophonphong, S.; Sercia, A.; Franca, C.M.; Tahayeri, A.; Reddy, A.P.; Wilmarth, P.A.; Surarit, R.; Smith, A.J.; Ferracane, J.L.; Bertassoni, L.E. Equivalence of human and bovine dentin matrix molecules for dental pulp regeneration: Proteomic analysis and biological function. Arch. Oral Biol. 2020, 119, 104888. [Google Scholar] [CrossRef] [PubMed]
  44. Chen, J.; Cui, C.; Qiao, X.; Yang, B.; Yu, M.; Guo, W.; Tian, W. Treated dentin matrix paste as a novel pulp capping agent for dentin regeneration. J. Tissue Eng. Regen. Med. 2017, 11, 3428–3436. [Google Scholar] [CrossRef] [PubMed]
  45. Kulakowski, D.; Leme-Kraus, A.A.; Nam, J.W.; McAlpine, J.; Chen, S.N.; Pauli, G.F.; Ravindran, S.; Bedran-Russo, A.K. Oligomeric proanthocyanidins released from dentin induce regenerative dental pulp cell response. Acta Biomater. 2017, 55, 262–270. [Google Scholar] [CrossRef]
  46. Wen, B.; Huang, Y.; Qiu, T.; Huo, F.; Xie, L.; Liao, L.; Tian, W.; Guo, W. Reparative Dentin Formation by Dentin Matrix Proteins and Small Extracellular Vesicles. J. Endod. 2021, 47, 253–262. [Google Scholar] [CrossRef] [PubMed]
  47. Xiong, Y.; Shen, T.; Xie, X. Effects of different methods of demineralized dentin matrix preservation on the proliferation and differentiation of human periodontal ligament stem cells. J. Dent. Sci. 2022, 17, 1135–1143. [Google Scholar] [CrossRef]
  48. Bakhtiar, H.; Mazidi, A.; Mohammadi-Asl, S.; Hasannia, S.; Ellini, M.R.; Pezeshki-Modaress, M.; Ostad, S.N.; Galler, K.; Azarpazhooh, A.; Kishen, A. Potential of Treated Dentin Matrix Xenograft for Dentin-Pulp Tissue Engineering. J. Endod. 2020, 46, 57–64. [Google Scholar] [CrossRef]
  49. Chang, C.C.; Lin, T.A.; Wu, S.Y.; Lin, C.P.; Chang, H.H. Regeneration of Tooth with Allogenous, Autoclaved Treated Dentin Matrix with Dental Pulpal Stem Cells: An In Vivo Study. J. Endod. 2020, 46, 1256–1264. [Google Scholar] [CrossRef]
  50. Meng, H.; Hu, L.; Zhou, Y.; Ge, Z.; Wang, H.; Wu, C.T.; Jin, J. A Sandwich Structure of Human Dental Pulp Stem Cell Sheet, Treated Dentin Matrix, and Matrigel for Tooth Root Regeneration. Stem Cells Dev. 2020, 29, 521–532. [Google Scholar] [CrossRef]
  51. Chen, G.; Sun, Q.; Xie, L.; Jiang, Z.; Feng, L.; Yu, M.; Guo, W.; Tian, W. Comparison of the Odontogenic Differentiation Potential of Dental Follicle, Dental Papilla, and Cranial Neural Crest Cells. J. Endod. 2015, 41, 1091–1099. [Google Scholar] [CrossRef] [PubMed]
  52. Guo, L.; Li, J.; Qiao, X.; Yu, M.; Tang, W.; Wang, H.; Guo, W.; Tian, W. Comparison of odontogenic differentiation of human dental follicle cells and human dental papilla cells. PLoS ONE 2013, 8, e62332. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Jiao, L.; Xie, L.; Yang, B.; Yu, M.; Jiang, Z.; Feng, L.; Guo, W.; Tian, W. Cryopreserved dentin matrix as a scaffold material for dentin-pulp tissue regeneration. Biomaterials 2014, 35, 4929–4939. [Google Scholar] [CrossRef] [PubMed]
  54. Li, H.; Sun, J.; Li, J.; Yang, H.; Luo, X.; Chen, J.; Xie, L.; Huo, F.; Zhu, T.; Guo, W.; et al. Xenogeneic Bio-Root Prompts the Constructive Process Characterized by Macrophage Phenotype Polarization in Rodents and Nonhuman Primates. Adv. Healthc. Mater. 2017, 6, 1601112. [Google Scholar] [CrossRef] [PubMed]
  55. Yang, Y.; Ge, Y.; Chen, G.; Yan, Z.; Yu, M.; Feng, L.; Jiang, Z.; Guo, W.; Tian, W. Hertwig’s epithelial root sheath cells regulate osteogenic differentiation of dental follicle cells through the Wnt pathway. Bone 2014, 63, 158–165. [Google Scholar] [CrossRef] [PubMed]
  56. Zhang, S.; Zhang, W.; Li, Y.; Ren, L.; Deng, H.; Yin, X.; Gao, X.; Pan, S.; Niu, Y. Human Umbilical Cord Mesenchymal Stem Cell Differentiation Into Odontoblast-Like Cells and Endothelial Cells: A Potential Cell Source for Dental Pulp Tissue Engineering. Front. Physiol. 2020, 11, 593. [Google Scholar] [CrossRef]
  57. Yang, H.; Li, J.; Hu, Y.; Sun, J.; Guo, W.; Li, H.; Chen, J.; Huo, F.; Tian, W.; Li, S. Treated dentin matrix particles combined with dental follicle cell sheet stimulate periodontal regeneration. Dent. Mater. 2019, 35, 1238–1253. [Google Scholar] [CrossRef] [PubMed]
  58. Li, M.; Yang, S.; Song, J.; Fu, T.; Liang, P.; Gao, Z.; Tang, J.; Guo, L. Different grinding speeds affect induced regeneration capacity of human treated dentin matrix. J. Biomed. Mater. Res. Part B Appl. Biomater. 2022, 110, 755–767. [Google Scholar] [CrossRef]
  59. Li, K.; Zhang, Z.; Sun, Y.; Yang, H.; Tsoi, J.; Huang, C.; Yiu, C. In vitro evaluation of the anti-proteolytic and cross-linking effect of mussel-inspired monomer on the demineralized dentin matrix. J. Dent. 2021, 111, 103720. [Google Scholar] [CrossRef]
  60. Omar, H.; Gao, F.; Yoo, H.; Bim, O.J.; Garcia, C.; LePard, K.J.; Mitchell, J.C.; Agostini-Walesch, G.; Carrilho, M.R. Changes to dentin extracellular matrix following treatment with plant-based polyphenols. J. Mech. Behav. Biomed. Mater. 2022, 126, 105055. [Google Scholar] [CrossRef]
  61. Okamoto, M.; Takahashi, Y.; Komichi, S.; Cooper, P.R.; Hayashi, M. Dentinogenic effects of extracted dentin matrix components digested with matrix metalloproteinases. Sci. Rep. 2018, 8, 10690. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Murata, M.; Kabir, M.A.; Hirose, Y.; Ochi, M.; Okubo, N.; Akazawa, T.; Kashiwazaki, H. Histological Evidences of Autograft of Dentin/Cementum Granules into Unhealed Socket at 5 Months after Tooth Extraction for Implant Placement. J. Funct. Biomater. 2022, 13, 66. [Google Scholar] [CrossRef] [PubMed]
  63. Li, P.; Zhu, H.; Huang, D. Autogenous DDM versus Bio-Oss granules in GBR for immediate implantation in periodontal postextraction sites: A prospective clinical study. Clin. Implant. Dent. Relat. Res. 2018, 20, 923–928. [Google Scholar] [CrossRef] [PubMed]
  64. Reis-Filho, C.R.; Silva, E.R.; Martins, A.B.; Pessoa, F.F.; Gomes, P.V.; de Araujo, M.S.; Miziara, M.N.; Alves, J.B. Demineralised human dentine matrix stimulates the expression of VEGF and accelerates the bone repair in tooth sockets of rats. Arch. Oral Biol. 2012, 57, 469–476. [Google Scholar] [CrossRef] [PubMed]
  65. Li, R.; Guo, W.; Yang, B.; Guo, L.; Sheng, L.; Chen, G.; Li, Y.; Zou, Q.; Xie, D.; An, X.; et al. Human treated dentin matrix as a natural scaffold for complete human dentin tissue regeneration. Biomaterials 2011, 32, 4525–4538. [Google Scholar] [CrossRef]
  66. Li, H.; Ma, B.; Yang, H.; Qiao, J.; Tian, W.; Yu, R. Xenogeneic dentin matrix as a scaffold for biomineralization and induced odontogenesis. Biomed. Mater. 2021, 16, 045020. [Google Scholar] [CrossRef] [PubMed]
  67. Yuan, Y.; Zhang, X.; Zhan, Y.; Tang, S.; Deng, P.; Wang, Z.; Li, J. Adipose-derived stromal/stem cells are verified to be potential seed candidates for bio-root regeneration in three-dimensional culture. Stem Cell Res. Ther. 2022, 13, 234. [Google Scholar] [CrossRef]
  68. Chen, G.; Chen, J.; Yang, B.; Li, L.; Luo, X.; Zhang, X.; Feng, L.; Jiang, Z.; Yu, M.; Guo, W.; et al. Combination of aligned PLGA/Gelatin electrospun sheets, native dental pulp extracellular matrix and treated dentin matrix as substrates for tooth root regeneration. Biomaterials 2015, 52, 56–70. [Google Scholar] [CrossRef]
  69. Wang, F.; Xie, C.; Ren, N.; Bai, S.; Zhao, Y. Human Freeze-dried Dentin Matrix as a Biologically Active Scaffold for Tooth Tissue Engineering. J. Endod. 2019, 45, 1321–1331. [Google Scholar] [CrossRef]
  70. Liu, S.; Sun, J.; Yuan, S.; Yang, Y.; Gong, Y.; Wang, Y.; Guo, R.; Zhang, X.; Liu, Y.; Mi, H.; et al. Treated dentin matrix induces odontogenic differentiation of dental pulp stem cells via regulation of Wnt/beta-catenin signaling. Bioact. Mater. 2022, 7, 85–97. [Google Scholar] [CrossRef]
  71. Tran, H.B.; Doan, V.N. Human dental pulp stem cells cultured onto dentin derived scaffold can regenerate dentin-like tissue in vivo. Cell Tissue Bank. 2015, 16, 559–568. [Google Scholar] [CrossRef] [PubMed]
  72. Liu, G.; Xu, G.; Gao, Z.; Liu, Z.; Xu, J.; Wang, J.; Zhang, C.; Wang, S. Demineralized Dentin Matrix Induces Odontoblastic Differentiation of Dental Pulp Stem Cells. Cells Tissues Organs 2016, 201, 65–76. [Google Scholar] [CrossRef]
  73. Fu, J.; Chen, J.; Li, W.; Yang, X.; Yang, J.; Quan, H.; Huang, H.; Chen, G. Laminin-Modified Dental Pulp Extracellular Matrix for Dental Pulp Regeneration. Front. Bioeng. Biotechnol. 2020, 8, 595096. [Google Scholar] [CrossRef] [PubMed]
  74. Na, S.; Zhang, H.; Huang, F.; Wang, W.; Ding, Y.; Li, D.; Jin, Y. Regeneration of dental pulp/dentine complex with a three-dimensional and scaffold-free stem-cell sheet-derived pellet. J. Tissue Eng. Regen. Med. 2016, 10, 261–270. [Google Scholar] [CrossRef] [PubMed]
  75. Holiel, A.A.; Mahmoud, E.M.; Abdel-Fattah, W.M.; Kawana, K.Y. Histological evaluation of the regenerative potential of a novel treated dentin matrix hydrogel in direct pulp capping. Clin. Oral Investig. 2021, 25, 2101–2112. [Google Scholar] [CrossRef] [PubMed]
  76. Holiel, A.A.; Mahmoud, E.M.; Abdel-Fattah, W.M. Tomographic evaluation of direct pulp capping using a novel injectable treated dentin matrix hydrogel: A 2-year randomized controlled clinical trial. Clin. Oral Investig. 2021, 25, 4621–4634. [Google Scholar] [CrossRef] [PubMed]
  77. Cunha, D.; Souza, N.; Moreira, M.; Rodrigues, N.; Silva, P.; Franca, C.; Horsophonphong, S.; Sercia, A.; Subbiah, R.; Tahayeri, A.; et al. 3D-printed microgels supplemented with dentin matrix molecules as a novel biomaterial for direct pulp capping. Clin. Oral Investig. 2022. [Google Scholar] [CrossRef]
  78. Bi, F.; Tang, H.; Zhang, Z.; Lyu, Y.; Huo, F.; Chen, G.; Guo, W. Hertwig’s epithelial root sheath cells show potential for periodontal complex regeneration. J. Periodontol. 2022. [Google Scholar] [CrossRef]
  79. Yang, X.; Ma, Y.; Guo, W.; Yang, B.; Tian, W. Stem cells from human exfoliated deciduous teeth as an alternative cell source in bio-root regeneration. Theranostics 2019, 9, 2694–2711. [Google Scholar] [CrossRef]
  80. Ji, B.; Sheng, L.; Chen, G.; Guo, S.; Xie, L.; Yang, B.; Guo, W.; Tian, W. The combination use of platelet-rich fibrin and treated dentin matrix for tooth root regeneration by cell homing. Tissue Eng. Part A 2015, 21, 26–34. [Google Scholar] [CrossRef]
  81. Luo, X.; Yang, B.; Sheng, L.; Chen, J.; Li, H.; Xie, L.; Chen, G.; Yu, M.; Guo, W.; Tian, W. CAD based design sensitivity analysis and shape optimization of scaffolds for bio-root regeneration in swine. Biomaterials 2015, 57, 59–72. [Google Scholar] [CrossRef] [PubMed]
  82. Guo, W.; Gong, K.; Shi, H.; Zhu, G.; He, Y.; Ding, B.; Wen, L.; Jin, Y. Dental follicle cells and treated dentin matrix scaffold for tissue engineering the tooth root. Biomaterials 2012, 33, 1291–1302. [Google Scholar] [CrossRef] [PubMed]
  83. Li, H.; Sun, J.; Yang, H.; Han, X.; Luo, X.; Liao, L.; Yang, B.; Zhu, T.; Huo, F.; Guo, W.; et al. Recruited CD68+ CD206+ macrophages orchestrate graft immune tolerance to prompt xenogeneic-dentin matrix-based tooth root regeneration. Bioact. Mater. 2021, 6, 1051–1072. [Google Scholar] [CrossRef] [PubMed]
  84. Wang, X.; Li, Q.; Lu, H.; Liu, Z.; Wu, Y.; Mao, J.; Gong, S. Effects of the Combined Application of Trimethylated Chitosan and Carbodiimide on the Biostability and Antibacterial Activity of Dentin Collagen Matrix. Polymers 2022, 14, 3166. [Google Scholar] [CrossRef]
  85. Moraes, G.F.; Caetano, R.O.; Prochnow, F.; Pupo, Y.M.; Schussel, J.L.; Schwartz-Filho, H.O. Demineralized human dentin matrix for alveolar ridge preservation using a volumetric and histologic analyses in rats. Braz. Dent. J. 2022, 33, 82–91. [Google Scholar] [CrossRef]
  86. Li, Y.; Zhou, W.; Li, P.; Luo, Q.; Li, A.; Zhang, X. Comparison of the osteogenic effectiveness of an autogenous demineralised dentin matrix and Bio-Oss® in bone augmentation: A systematic review and meta-analysis. Br. J. Oral Maxillofac. Surg. 2022, 60, 868–876. [Google Scholar] [CrossRef]
  87. Um, I.W.; Kim, Y.K.; Park, J.C.; Lee, J.H. Clinical application of autogenous demineralized dentin matrix loaded with recombinant human bone morphogenetic-2 for socket preservation: A case series. Clin. Implant. Dent. Relat. Res. 2019, 21, 4–10. [Google Scholar] [CrossRef]
  88. Han, J.; Jeong, W.; Kim, M.K.; Nam, S.H.; Park, E.K.; Kang, H.W. Demineralized Dentin Matrix Particle-Based Bio-Ink for Patient-Specific Shaped 3D Dental Tissue Regeneration. Polymers 2021, 13, 1294. [Google Scholar] [CrossRef]
  89. Ozdemir, O.; Kopac, T. Cytotoxicity and biocompatibility of root canal sealers: A review on recent studies. J. Appl. Biomater. Funct. Mater. 2022, 20, 1597430629. [Google Scholar] [CrossRef]
  90. Chen, H.; Zhang, Y.; Yu, T.; Song, G.; Xu, T.; Xin, T.; Lin, Y.; Han, B. Nano-Based Drug Delivery Systems for Periodontal Tissue Regeneration. Pharmaceutics 2022, 14, 2250. [Google Scholar] [CrossRef]
  91. Ozdemir, O.; Kopac, T. Recent Progress on the Applications of Nanomaterials and Nano-Characterization Techniques in Endodontics: A Review. Materials 2022, 15, 5109. [Google Scholar] [CrossRef] [PubMed]
  92. Wilson, C.J.; Clegg, R.E.; Leavesley, D.I.; Pearcy, M.J. Mediation of biomaterial-cell interactions by adsorbed proteins: A review. Tissue Eng. 2005, 11, 1–18. [Google Scholar] [CrossRef] [PubMed]
  93. Kopac, T. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review. Int. J. Biol. Macromol. 2021, 169, 290–301. [Google Scholar] [CrossRef] [PubMed]
Pharmaceutics 15 00091 g001 550
Figure 1. Treated dentin matrix image taken using SEM, where exposed dentinal tubules are shown.
Figure 1. Treated dentin matrix image taken using SEM, where exposed dentinal tubules are shown.
Pharmaceutics 15 00091 g001
Pharmaceutics 15 00091 g003 550
Figure 3. Basic procedure to obtain a treated dentin matrix.
Figure 3. Basic procedure to obtain a treated dentin matrix.
Pharmaceutics 15 00091 g003
Pharmaceutics 15 00091 g004 550
Figure 4. Treated-dentin-matrix-based bio-root construction. AB: alveolar bone, PDL: periodontal ligament, C: cementum, D: dentin, PD: pre-dentin, OB: odontoblast, DP: dental pulp.
Figure 4. Treated-dentin-matrix-based bio-root construction. AB: alveolar bone, PDL: periodontal ligament, C: cementum, D: dentin, PD: pre-dentin, OB: odontoblast, DP: dental pulp.
Pharmaceutics 15 00091 g004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bi, F.; Zhang, Z.; Guo, W. Treated Dentin Matrix in Tissue Regeneration: Recent Advances. Pharmaceutics 2023, 15, 91. https://doi.org/10.3390/pharmaceutics15010091

AMA Style

Bi F, Zhang Z, Guo W. Treated Dentin Matrix in Tissue Regeneration: Recent Advances. Pharmaceutics. 2023; 15(1):91. https://doi.org/10.3390/pharmaceutics15010091

Chicago/Turabian Style

Bi, Fei, Zhijun Zhang, and Weihua Guo. 2023. "Treated Dentin Matrix in Tissue Regeneration: Recent Advances" Pharmaceutics 15, no. 1: 91. https://doi.org/10.3390/pharmaceutics15010091

APA Style

Bi, F., Zhang, Z., & Guo, W. (2023). Treated Dentin Matrix in Tissue Regeneration: Recent Advances. Pharmaceutics, 15(1), 91. https://doi.org/10.3390/pharmaceutics15010091

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop